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Cases of Aeromonas diarrhea have been described all over the world. The genus
Aeromonas includes ca. 30 species, of which 10 have been isolated in association
with gastroenteritis. The dominating species that account for ca. 96% of the identified
strains are Aeromonas caviae, A. veronii, A. dhakensis, and A. hydrophila. However, the
role of Aeromonas as a true enteropathogen has been questioned on the basis of the
lack of outbreaks, the non-fulfillment of Koch’s postulates and the low numbers of acute
illnesses in the only existing human challenge study. In the present study we reassess the
enteropathogenicity of Aeromonas using dose response models for microbial infection
and acute illness. The analysis uses the data from the human challenge study and
additional data from selected outbreak investigations where the numbers exposed
and the dose were reported, allowing their inclusion as “natural experiments”. In the
challenge study several cases of asymptomatic shedding were found (26.3%, 15/57),
however, only 3.5% (2/57) of those challenged with Aeromonas developed acute enteric
symptoms (i.e., diarrhea). The “natural experiments” showed a much higher risk of illness
associated with exposure to Aeromonas, even at moderate to low doses. The median
dose required for 1% illness risk, was ∼1.4 × 104 times higher in the challenge study
(1.24 × 104 cfu) compared to natural exposure events (0.9 cfu). The dose response
assessment presented in this study shows that the combined challenge and outbreak
data are consistent with high infectivity of Aeromonas, and a wide range of susceptibility
to acute enteric illness. To illustrate the outcomes, we simulate the risk associated with
concentrations of Aeromonas found in different water and food matrices, indicating
the disease burden potentially associated with these bacteria. In conclusion this study
showed that Aeromonas is highly infectious, and that human susceptibility to illness may
be high, similar to undisputed enteropathogens like Campylobacter or Salmonella.
Keywords: Aeromonas, outbreaks, water, food, challenge study, infective dose, risk of infection, risk of illness
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INTRODUCTION
The genus Aeromonas, includes Gram-negative, non-spore-
forming rods that are autochthonous of the aquatic environments
worldwide (Austin et al., 1996; Janda and Abbott, 2010; Figueras
and Beaz-Hidalgo, 2015; Graf, 2015). In humans diarrhea, and
wound infections are the most common presentation followed
by bacteremia (Figueras, 2005; von Graevenitz, 2007; Janda and
Abbott, 2010; Figueras and Beaz-Hidalgo, 2015). Isolation of
Aeromonas in patients with diarrhea varies from ca 2 to 10%
but a higher incidence (13%) has been found in children from
Nigeria (Figueras and Beaz-Hidalgo, 2015). Also a significantly
higher incidence of Aeromonas is found in patients with diarrhea
than in those considered asymptomatic carriers (Figueras, 2005;
Janda and Abbott, 2010; Figueras and Beaz-Hidalgo, 2015).
Typical susceptible patients in the different studies include babies,
young children and the elderly and especially those with a pre-
existing illness and/or immunocompromised (Janda and Abbott,
2010; Figueras and Beaz-Hidalgo, 2015). According to Janda and
Abbott (2010) it is important to report the presence of Aeromonas
in stools of immunocompromised patients even if they are only
asymptomatic because the risk of invasion and dissemination is
considered inherently high for these patients. Nevertheless the
role of Aeromonas in gastroenteritis has been questioned (Janda
and Abbott, 1998, 2010; Chu et al., 2006; von Graevenitz, 2007),
mainly because 55 out 57 challenged volunteers with a high
dose of Aeromonas did not developed any symptoms of enteric
illness, and due to the few reported outbreaks (Morgan et al.,
1985; Figueras et al., 2007b; Janda and Abbott, 2010; Figueras and
Beaz-Hidalgo, 2015). However, there are also many publications
providing support for a causal relation between Aeromonas and
enteric disease (Figueras et al., 2007a,b; Janda and Abbott, 2010;
Figueras and Beaz-Hidalgo, 2015). Although 10 of the ca. 30
species that comprise the genus have been isolated in association
with gastroenteritis, only 4, i.e., Aeromonas caviae, A. veronii,
A. dhakensis, and A. hydrophila are the dominating species
accounting for ca. 96% of the recovered isolates from this origin
in different studies (Figueras and Beaz-Hidalgo, 2015).
Consumption of contaminated water and food are considered
the main routes of transmission and there are few reports of
well documented outbreaks that include information about the
ingested doses of Aeromonas (Krovacek et al., 1995; Granum
et al., 1998; Zhang et al., 2012). An association between diarrheal
cases and consumption of untreated or contaminated drinking
water has been established in several occasions (Holmberg et al.,
1986; Martin Delgado et al., 2001; Khajanchi et al., 2010; Pablos
et al., 2011; Ventura et al., 2015). Aeromonas was isolated from
drinking water and stools in some patients that were diagnosed
with traveler’s diarrhea among the tourists that visited specific
hotels in the coastal area of Tenerife and Canary Islands in
Spain (Martin Delgado et al., 2001). Failures in the drinking
water distribution system caused fecal contamination of the
water, as revealed by the presence of bacterial indicators of
fecal pollution, high concentrations of organic matter and the
detection of Aeromonas (Martin Delgado et al., 2001). Once
the water distribution system was repaired the incidence of
diarrhea among the tourist population returned to normal. Even
a recurrent case of Aeromonas bacteremia has been attributed to
the consumption of contaminated well water (Katz et al., 2015).
Use of contaminated water can cause secondary contamination of
food products, and this can be the source of food-borne outbreaks
(Altwegg et al., 1991; Krovacek et al., 1995; Granum et al., 1998;
Figueras and Borrego, 2010; Wadhwa et al., 2012; Zhang et al.,
2012; Figueras and Beaz-Hidalgo, 2014).
It has become generally accepted that only a subset of
Aeromonas strains can cause gastroenteritis in humans (von
Graevenitz, 2007; Janda and Abbott, 2010; Grim et al., 2014).
However, nowadays it is clear that infection is a complex process
in which not only the virulence of the colonizing strain is
important, but also its interaction with other microbes that are
present in the gut, as co-infecting pathogens or in the natural
microbial ecosystem, together with the specific physiological
status of the host (Lund and O’Brien, 2011; Leggett et al., 2012;
Beaz-Hidalgo and Figueras, 2013; Mosser et al., 2015; Ribet
and Cossart, 2015; Denny et al., 2016). In fact, the overall
crosstalk and interactions between commensal bacteria, enteric
pathogens, and host physiology is what is considered crucial to
the establishment and progression of intestinal disease (Leggett
et al., 2012; Ribet and Cossart, 2015).
Challenge studies have been essential, to establish a causal
relation between exposure and health effects and for quantifying
the dose response relation (Teunis et al., 1996; Teunis and
Havelaar, 2000). However, some outbreak reports include data
on the numbers of person exposed, and even information
allowing an estimate of the magnitude of the dose involved.
Such outbreaks may be treated as ’natural experiments or
natural exposure’, comparable to a challenge experiment with
a single dose group (Teunis et al., 2004, 2008, 2012b). Both
data sources have been successfully used in several studies that
investigated the potential of human pathogens different from
Aeromonas for producing colonization (infectivity) and acute
illness (pathogenicity) (Teunis et al., 2005, 2010).
In the present study we use dose response models for
microbial infection and acute illness (Teunis et al., 1999;
Teunis and Havelaar, 2000) to re-assess the Morgan et al.
(1985) challenge study and combine these data with outbreak
investigations to determine the dose response relation for
producing infection and acute enteric disease by Aeromonas
spp. Furthermore, to illustrate the outcomes, we estimate the
risk associated with waterborne exposure to these bacteria
using reference concentrations found in different water or
food matrices. In addition we provide evidence in support of
Aeromonas acting as a true enteropathogen.
MATERIALS AND METHODS
Data Used in the Dose Response Model
The volunteer protocols for the Morgan et al. (1985) human
challenge study were approved by the institutional review boards
of the University of Texas Health Science Center, Baylor College
of Medicine, The Methodist Hospital and the General Clinical
Research Center, and as common in a dose response study,
did not include a non-exposed control group. The five different
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Aeromonas strains that were administered orally in a bicarbonate
solution to 57 adult healthy human volunteers at a range of doses
and the outcomes obtained (Morgan et al., 1985) are summarized
in Table 1. A prechallenge stool was cultured for enteropathogens
from all volunteers before admission, and volunteers abstained
from eating and drinking 90 min before and after oral challenge.
Volunteers were followed up with a daily physical examination
to determine symptoms of gastroenteritis (defined as 2 or more
unformed stools in 24 h accompanied by any symptoms of enteric
disease). Infection was defined as fecal shedding of the inoculated
strain detected by analysis of the volunteer’s feces.
One of the subjects who was challenged with strain 3647
developed acute enteric symptoms, while no shedding of the
inoculated strain could be detected. This outcome could indicate
a false positive for symptoms, if the enteric symptoms in this
subjects were caused by something different, unrelated to the
challenge. It could also be a false negative infection, where
this subject had been colonized without detectable pathogen
shedding. Such false negative shedding has been reported in
other challenge studies (DuPont et al., 1969), possibly indicating
intermittent shedding or low sensitivity of the detection method.
Given the setting of inoculation with a high dose, we consider
the second alternative (false negative infection) most plausible. In
addition to these clinical experiment data, a literature review was
done to collect data on acute enteric illness caused by Aeromonas
due to natural exposures or outbreaks (here called “natural
experiments”). Only studies where sufficient information was
reported to allow a dose response assessment were selected.
Four “natural experiments” with these characteristics were found:
3 foodborne outbreaks (Krovacek et al., 1995; Granum et al.,
1998; Zhang et al., 2012) and an incident where a laboratory
TABLE 1 | Strains of Aeromonas and doses challenged to different groups
of volunteers (data from Morgan et al., 1985).
Dose Volunteers
Strain (cfu) Challenged Infected Illness
6Y 2 × 104 4 1 0
1 × 106 4 1 0
7 × 107 4 4 0
3 × 109 4 3 1
4 × 1010 4 2 0
B158 6 × 104 4 0 0
2 × 107 4 0 0
3647 1 × 107 4 1a 1
4 × 107 4 0 0
2 × 109 4 2 0
3 × 1010 4 1 0
SSU 4 × 108 4 0 0
5 × 1010 3 0 0
3284 3 × 108 3 0 0
1 × 1010 3 0 0
aAccording to Morgan et al. (1985), there was not infection but it was only acute
illness, however, this could be either a false negative or a false positive (as explained
in the materials and methods). Given the setting of inoculation with a high dose, we
consider the first alternative (false negative infection) most plausible.
worker had accidentally ingested a pure culture of 109 Aeromonas
(Carnahan et al., 1991). The data used from those studies are
summarized in Table 2. To our knowledge these are the only
reports that include numbers of exposed subjects and numbers
of acute cases, and information on exposure, either as estimated
numbers of ingested bacteria or as amount of the contaminated
food product consumed (Table 2). The foodborne outbreak
reported by Zhang et al. (2012) showed a dose response relation
between the amounts of food consumed (cucumber salad) and
the observed attack rate.
Dose Response Assessment
Conceptually, three stages may be identified when a subject
is challenged: exposure, infection, and (acute) illness. For
exposure, it is important to realize that many microbial
pathogens are highly infectious. Whenever a person ingests
a quantity of contaminated food or drink, they only need
to swallow few pathogenic particles to become infected. If
the concentration of pathogens in the contaminated food or
drink is low, the probability that the ingested portion did
not contain any pathogens may be substantial. If (and only
if) a person is exposed, there is a non-zero probability that
any of the ingested pathogens survives all host barriers and
succeeds in colonizing host tissues (i.e., infection is conditional
on exposure). Likewise, if (and only if) a person is infected,
there is a non-zero probability that the colonizing pathogen
expresses pathogenicity producing damage of host tissues leading
to symptoms of (acute) illness (i.e., illness is conditional on
infection). Thus, there are two conditional probabilities: the
probability of infection given exposure, and the probability
of (acute) illness given infection. Both probabilities may be
dose dependent, so that there are two dose response relations:
one for infection, and the second for illness among infected
subjects. Mathematical details for these two dose response
relations are given in the Supplementary Material, where it
is also indicated that all analyses were performed using JAGS
(v4.2.0), with post-processing (graphs and additional statistics)
in R (v3.3.1).
The parameters for these dose response relations,
characterizing susceptibility to infection and to illness when
infected, were estimated in a hierarchical framework. Each strain
in the challenge study was treated as a separate trial, leading to
strain-specific dose response relations for infection and illness.
Similarly, each “natural experiment” was treated separately,
as described by its own distinct dose response relations, for
infection and illness. In the hierarchical framework, the variation
in the parameters among these separate dose response relations
is described by a (joint) distribution, representing the “group”
pattern for all studies combined (Teunis et al., 2008). Hence,
using all studies combined, it is possible to make predictions
of the dose response relations for infection and illness, for any
Aeromonas as representing a random sample from a population
characterized by the combined studies shown in Tables 1 and 2.
In a subsequent analysis the challenge studies and the natural
experiments were compared by assigning each of these two
categories different susceptibilities to infection and illness. These
separate predictions of the dose response relations for the
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TABLE 2 | Dose and/or concentrations of Aeromonas found in the ingested matrices and number of exposed and cases showing acute gastrointestinal
symptoms in outbreaks or natural experiments.
Reference Matrix Intake Concentration cfu/g Exposed Ill
Zhang et al., 2012a Cucumber salad 2 tbsp NA 178 73
1 tbsp NA 153 59
0.5 tbsp NA 141 39
Krovacek et al., 1995b Swedish salad 50 g 106–107 27 24
Granum et al., 1998b Fermented fish 107 4 3
Carnahan et al., 1991b Broth of a pure culture 109
NA = not available; tbsp = table spoon; a Intake of food (cucumber salad) with unknown concentration, so the concentration was estimated in this study (Figure 1). bThe
concentration is the dose given by the authors.
FIGURE 1 | Estimated (posterior) distribution of the concentration
(cfu/g) of Aeromonas in the cucumber salad derived using the intake
data described in the outbreak reported by Zhang et al. (2012).
challenge study strains and for the natural exposure events may
thus be compared.
Note that in the foodborne outbreak described by Zhang
et al. (2012) the intake of contaminated food was reported, but
not the concentration of bacteria or its possible inhomogeneous
distribution in that food due to clustering occurrence. Assuming
the dose is proportional to the amount consumed, the
concentration of bacteria may be added as another parameter
(Teunis et al., 2005). This allows estimation of the mean
dose (show in Figure 1) even in case there is heterogeneity
because of an uneven distribution of bacteria (clustering) in
the contaminated food. Unfortunately, the information available
does not allow quantitative characterization of this heterogeneity
as done in previous studies (Teunis et al., 2008).
Estimation of Risk
To illustrate the use of the inferred dose response models, Monte
Carlo samples of the dose response parameters for infection
and (conditional) illness were used to calculate risks of infection
and (acute enteric) illness for a few exposure scenarios. The
probabilities of infection and illness resulting from exposure
to low, medium, and high doses (10, 1000, and 106 cfu) of
Aeromonas were calculated, using the dose response models
for infection and illness (see annex Supplementary Material).
The selected scenarios represent concentrations of Aeromonas
commonly found in drinking water distribution systems or food
products like milk, meat products or shellfish (Abeyta et al., 1986;
Austin et al., 1996; Borrell et al., 1998; Figueras et al., 2005;
Egorov et al., 2011; Wadhwa et al., 2012; Robertson et al., 2014)
or contaminated water (rivers, lakes) with treated or untreated
wastewater (Austin et al., 1996; Borrell et al., 1998; McMahon
and Wilson, 2001; Janda and Abbott, 2010; Latif-Eugenín, 2015;
Fernandez-Cassi et al., 2016).
RESULTS
Dose Response Assessment
The calculated estimated concentration of Aeromonas in the
cucumber salad that was the vehicle for exposure in the outbreak
reported by Zhang et al. (2012), is shown in Figure 1 and
ranged between 200 and 1000 cfu/g. So the likely dose in that
outbreak was lower than the doses in the challenge study (see
Supplementary Material for details).
In an initial analysis the data from the challenge study and
the outbreaks (natural experiments or natural exposure events)
were assumed to be similar and were represented by single
joint distributions (Figure 2) that showed the susceptibility to
infection (i.e., the probability of infection per ingested bacteria)
and to illness (i.e., the probability of illness per ingested bacteria).
This unsegmented approach resulted in a single predicted dose-
response relation for illness, as show in Figure 2, with a broad
posterior range in illness probabilities, indicating substantial
heterogeneity in illness risk. In Figure 2 it can be observed
that the data from the “natural experiments” (i.e., outbreaks or
natural exposure events) cluster at higher illness probabilities
compared to the challenge study data. Based on these different
outcomes, a refined model was set up, with separate categories
for the challenge study and the “natural experiments” that
represented two different distributions of susceptibility. The
resulting separate dose response models for the challenge study
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FIGURE 2 | Predicted dose response relation for acute enteric illness
assuming a single class of infectivity and pathogenicity. Median
probability of illness (solid black line) and 95% predictive intervals (dotted
lines). The five strains (6Y, B158, 3647, SSU, and 3284) used in the challenge
study show a low virulence (data in Table 1), and the four natural experiments
(Zh = Zhang et al., Kr = Krovacek et al., Gr = Granum et al., Ca = Carnahan
et al.) show a high virulence (data in Table 2). Plot symbols show observed
fractions, data from the same strain/experiment are connected. Sizes of
symbols indicate numbers of subjects exposed.
and “natural exposure events” were markedly different, as shown
in Figure 3. For the challenge study, ingestion of even very
high doses of 1012 cfu results in low risk of acute illness
(approximately 0.1, 95% range 0–0.45) as shown in Figure 3.
Note, however, that even this low risk is caused by only two
positive responses, with two different strains (3647 and 6Y),
out of a total of 57 subjects exposed. In an alternative analysis
where the symptomatic case for strain 3647 was considered a
false positive, the resulting dose response models (not shown
here) were virtually identical to those in Figures 2 and 3. Of
those exposed, 15 were infected, indicating that infection was
a lot more common than symptomatic acute illness, and also
that pathogenicity may have been different among strains. For
the “natural exposure events” the illness risk was much higher
(approximately 0.5, 95% range 0.05–1.0), even at a comparatively
low dose of 103 cfu (Figure 3, lower graphic).
Figure 4 shows infection dose response relations for the
challenge study and the “natural exposure” data. As infection is
a condition for illness, the probability of infection must be at
least as high as the illness probability (compare Figures 3 and 4).
The natural exposure event data do not include any observation
of infections, as this is a covert outcome (it cannot be observed
directly), but because illness depends on infection the probability
of infection can still be estimated. As the illness risk was high in
these “natural experiments”, the infection probabilities must be
high as well, as shown in Figure 4.
The estimated susceptibilities for infection and illness were
illustrated also by the doses required to cause a 1% probability of
infection for each of the challenge strains, and separately for each
FIGURE 3 | Predicted dose response relations for acute enteric illness,
derived from the five strain (6Y, B158, 3647, SSU, and 3284) of the
challenge study (upper graphic showing a low susceptibility) and the
four natural experiments (Zh = Zhang et al., Kr = Krovacek et al.,
Gr = Granum et al., Ca = Carnahan et al., lower graphic showing a
high susceptibility). Median probability of illness (solid black line) and 95%
predictive intervals (dotted lines). Plot symbols show observed fractions, data
from the same strain/experiment are connected. Sizes of symbols indicate
numbers of subjects exposed.
of the “natural exposure events” (Table 3; Figure 5). Estimates for
the two prediction categories: low susceptibility for the challenge
studies and high susceptibility for the “natural experiments” are
shown in Figure 5 for infection and for illness risks. An outcome
of 1% risk was chosen here because in the challenge studies the
risk was so low that calculation of 50% infectious (and illness)
doses results in unrealistically high numbers. Mean and median,
as well as a 95% range are also given in Table 3.
Estimation of Risk
To illustrate the application of the dose response models derived
here, a small risk study was set up, using a simple scenario
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FIGURE 4 | Predicted dose response relations for infection, derived
from the five strain (6Y, B158, 3647, SSU, and 3284) of the challenge
study (upper graphic showing a low susceptibility) and the four natural
experiments (Zh = Zhang et al., Kr = Krovacek et al., Gr = Granum
et al., Ca = Carnahan et al., lower graphic showing a high
susceptibility). Median probability of infection (solid black line) and 95%
predictive intervals (dotted lines). Plot symbols show observed fractions, data
from the same strain/experiment are connected. Sizes of symbols indicate
numbers of subjects exposed.
of three different, fixed doses, representing low, medium, and
high exposure. Figure 6 shows the resulting risks of Aeromonas
infection and illness. It is clear that using the challenge study
dose response relation, the illness risk remains small, even for
exposure to considerable doses of Aeromonas. On the other hand,
the natural exposure events dose response relation produces high
illness risks, even when the dose is moderate or low.
DISCUSSION
The major clinical manifestation produced by Aeromonas
is diarrhea affecting principally young children and
immunocompromised patients (Janda and Abbott, 2010;
Figueras and Beaz-Hidalgo, 2015). The single available human
challenge study for Aeromonas shows low susceptibility, in
particular to developing acute enteric symptoms with only 2/57
(3.5%) challenged being positive (Table 1; Morgan et al., 1985).
In contrast, the “natural exposure events” indicate that a high
risk of illness may be associated with exposure to Aeromonas
even at moderate to low doses. Thus, host susceptibility may be
a strong determinant for the illness risk of Aeromonas sp. The
dose response assessment presented in this study corroborates
this conclusion (median 1% illness dose was ∼1.4 × 104 times
higher in “the natural exposure events” compared to the clinical
challenge), and shows how these two subsets of illness data lead
to different estimates of susceptibility.
Although invaluable for understanding infection and
pathogenesis, clinical challenge may not quantitatively represent
natural infection that occur during an outbreak. Clinical
challenge may underestimate the risk because pathogen inocula
may decrease in virulence because of safety testing, often
requiring repeated culture in the laboratory. Likewise, volunteers
are selected for being healthy and immunocompetent to reduce
the risk of serious complications. Conversely, outbreaks select
for virulent pathogen strains and susceptible hosts, as this
increases the probability that a cluster of cases is detected (Teunis
et al., 2004). Consequently, challenge studies and outbreaks
may both be biased, in opposite directions: each may represent
an extreme in the continuum of dose response relations as
discussed earlier (Teunis et al., 2005, 2010; Thebault et al.,
2013). Outbreaks or natural exposure events may select for
highest susceptibility in the affected host population producing
a high illness risks, even when the dose is moderate or low.
For instance in the food outbreak that produced acute diarrhea
in over 200 college students’ described by Zhang et al. (2012)
the estimated concentration of Aeromonas in the cucumber
salad determined in the present study ranged from 200 to
1000 cfu/g (Figure 1). This estimated concentration assumed
a homogeneous distribution of bacteria (Teunis et al., 2005)
in the cucumber salad. As the origin of the contamination in
this outbreak was attributed to rinse water of the vegetables,
contaminated with sewage, occurrence of bacteria may not have
been severely clustered. In case there is severe clustering, some
subjects would have been exposed to high doses, while others
would not have been exposed at all. Only when there is extreme
clustering, the slope of the dose response relation is affected,
not its location and the mean dose remains proportional to
the amount of contaminated food that was ingested (Teunis
et al., 2008, 2012a). As no information regarding clustering
in the contaminated cucumber salad was provided by Zhang
et al. (2012), any assumptions regarding clustering would be
speculation.
Little is known about who is susceptible to any specific
strain or pathogen in the population at large, or how
many of the already considered susceptible like infants or
immunocompromised would develop acute illness. It has been
estimated that in developed countries the part of the population
that could be susceptible to acquiring a foodborne disease would
be near 20% (Lund and O’Brien, 2011; Lund, 2015). Challenge
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TABLE 3 | Doses (mean, median, and 95% CI) for 1% risk of infection and illness calculated for each individual strain/natural experiment, and globally for
all strain/natural experiments (corresponding to the low/high susceptibility situations).
1% Infectious dose 1% Illness dose
Mean Median 95% CI Mean Median 95% CI
6Ya 1.04 0.56 0.07–4.95 1.47 × 104 60.8 4.19–5.09 × 103
B158a 1893.6 2.58 0.15–126.5 1.90 × 109 4.97 × 105 126.0–2.67 × 1010
3647a 2.69 1.27 0.12–14.6 2.94 × 108 8400.7 53.6–1.54 × 109
SSUa 412.1 3.20 0.14–191.4 2.48 × 109 1.22 × 106 215.1–3.77 × 1010
3284a 2839.6 2.93 0.14–163.5 2.26 × 109 6.10 × 105 189.6–3.30 × 1010
Zhb 0.14 0.05 0.01–0.68 3.94 1.28 0.054–22.67
Krb 0.10 0.04 0.01–0.55 1.98 0.82 0.063–10.88
Grb 0.12 0.04 0.01–0.70 3.90 0.94 0.058–24.95
Cab 0.12 0.04 0.01–0.68 331.8 0.85 0.064–31.76
Low Suscc 385.1 1.67 0.10–61.2 7.61 × 108 1.24 × 104 11.76–7.60 × 109
High Suscc 0.12 0.04 0.01–0.73 21.88 0.90 0.064–50.67
aStrains used in the Morgan et al. (1985) challenge study. bNatural experiments or outbreaks from: Zh = Zhang et al. (2012); Kr = Krovacek et al. (1995); Gr = Granum
et al. (1998); Ca = Carnahan et al. (1991). cLow and high susceptibility correspond to the 1% dose calculated globally for all the strains and for the natural experiments
or outbreaks, respectively.
studies, on the other hand, tend to select for low susceptibility,
and may represent the opposite extreme of the susceptibility
spectrum. The results presented here for Aeromonas appear to
support the same conclusion, where the outbreaks represent a
worst case situation, while most challenged exposures result in
low risk of infection and illness.
As indicated before the results of the Morgan et al. (1985)
challenge study have been used to indicate that Aeromonas is
not a true gastrointestinal pathogen (von Graevenitz, 2007; Janda
and Abbott, 2010). However, it must be noted that 15 out of 57
(26%) were infected. The occurrence of few illness outcomes is
not rare in human challenge studies. For instance in a challenge
study for Giardia lamblia 40 subjects were challenged, with doses
up to 106 cysts resulting in 21 infected subjects, yet not a single
of these infected subjects showed any symptoms of enteric illness
(Rendtorff, 1954). Nevertheless, the significance of Giardia as a
human enteric pathogen is not doubted. The same may be found
for Plesiomonas shigelloides with 22 subjects challenged, resulting
in eight infected and none of these becoming ill (Herrington
et al., 1987). The 3.5% acute diarrhea incidence of the Morgan
et al. (1985) study is similar to the 2% of adult diarrhea incidence
found in several studies (Svenungsson et al., 2000; Vila et al.,
2003; Figueras, 2005; Senderovich et al., 2012; Figueras and
Beaz-Hidalgo, 2015).
The above analysis suggests that the natural exposures involve
much lower doses than the challenge study. Notwithstanding
the low risk predicted from the challenge study data, the same
study suggests that the risk of infection is not extremely low,
in particular for two of the strains 6Y and 3647 (Morgan et al.,
1985). This means that the risk cannot be ignored, even though
few cases of acute diarrhea were observed. Janda and Abbott
(2010) underlined that the strain SSU (CDC diarrheal isolate),
which is probably the most well-characterized Aeromonas strain
with respect to virulence factors (i.e., carriage and expression
of enterotoxin genes, and potential colonization factors see
studies directed by Dr. Chopra, i.e., Grim et al., 2014 and
Ponnusamy et al., 2016, and references therein) did not produce
infection (colonization) nor diarrhea in the challenge study,
so this cannot support the idea that the strains were wrongly
selected. However, it is still possible that a critical virulence or
colonization factor could have been lost when subculturing the
original strains (Morgan et al., 1985; Janda and Abbott, 2010).
Experimental studies in a murine animal model showed that
the injection of strain SSU generated the death of all mice in
48 h (Grim et al., 2014; Ponnusamy et al., 2016). Strain SSU
has been recently identified as Aeromonas dhakensis, a highly
virulent species (Beaz-Hidalgo et al., 2013; Morinaga et al., 2013;
Figueras and Beaz-Hidalgo, 2015), instead of A. hydrophila as
originally thought (Morgan et al., 1985). It is now known that the
importance attributed to A. hydrophila is due to misidentification
of the majority of strains as belonging to this species, using
phenotypic identification systems (Soler et al., 2003; Figueras,
2005; Beaz-Hidalgo et al., 2010; Morinaga et al., 2013). In fact
even 30% of the genomes deposited at the GenBank database
with the name of A. hydrophila do not belong to this species
(Figueras et al., 2014; Beaz-Hidalgo et al., 2015). Old literature
on clinical aeromonads limited the identification only to three
species, i.e., A. hydrophila, A. sobria (the correct terminology
for the clinical strains is A. veronii biovar sobria) and A. caviae
(Janda and Abbott, 1998; Figueras, 2005; von Graevenitz, 2007).
However, strains under these names may belong to other species
(Janda and Abbott, 1998; Soler et al., 2003; Figueras, 2005).
For instance in the Morgan et al. (1985) study among the five
strains named A. hydrophila three (6Y, B158, and 3284) were
suspected to belong to A. sobria (A. veronii biovar sobria), and
strain SSU, as commented above, corresponds to A. dhakensis.
A recent review showed that when using molecular identification
methods ca. 96% of the recovered isolates (313/327) from human
feces in different studies belong to 4 species: A. caviae (37.6%),
A. veronii (27.2%), A. dhakensis (16.5%), and A. hydrophila
(14.5%) (Figueras and Beaz-Hidalgo, 2015). A higher prevalence
of A. caviae in diarrhea cases over the other species is reported
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FIGURE 5 | Box plots showing the estimated doses required for 1% probability of infection (InfD01, upper graphic) and illness (IllD01, lower graphic).
Results in both graphics are provided for each individual strain (6Y, B158, 3647, SSU, and 3284) and experiment (Zh = Zhang et al., Kr = Krovacek et al.,
Gr = Granum et al., Ca = Carnahan et al.) and globally for all strains (i.e., low susceptibility) and natural experiments (i.e., high susceptibility).
also in previous reviews (von Graevenitz, 2007). However, studies
on traveler’s diarrhea where an adult population is involved are
dominated by A. veronii (Vila et al., 2003; von Graevenitz, 2007
and references therein). Also in a recent study performed by Chen
et al. (2015) in and adult population from Taiwan A. veronii was
the prevailing species (54.6%) followed by A. caviae (27.6%), and
with one strain of each of the species A. dhakensis (9.1%) and
A. sanarellii (9.1%). Interestingly one patient in the latter study
had a history of eating lettuce with salad prior to the illness. In a
recent study tomatoes and parsley irrigated with the same water
showed the same genotype of a strain of A. sanarellii and the same
occurred for an A. caviae strain recovered from the water and the
irrigated lettuces (Latif-Eugenín, 2015).
As we commented in the introduction it is generally assumed
that the virulence of Aeromonas is multifactorial and that only a
subset of Aeromonas strains is capable of causing gastroenteritis
in humans (von Graevenitz, 2007; Janda and Abbott, 2010;
Beaz-Hidalgo and Figueras, 2013; Figueras and Beaz-Hidalgo,
2014; Grim et al., 2014; Ponnusamy et al., 2016). In fact some
Aeromonas strains possess several virulence toxins and secretion
systems, among which the Type III secretion system and the
Shiga toxin genes are similar to those present in other important
pathogenic bacteria (Figueras et al., 2007a; Alperi and Figueras,
2010; Figueras and Beaz-Hidalgo, 2014). The large variation
observed among Aeromonas strains maybe linked to the site
where the virulence is expressed (Leggett et al., 2012). For
instance carriage of virulence genes that have a local action
within the host cells like, i.e., the injection of toxins through
the Type III or Type IV secretion systems may generate a
more virulent response than other strains that exert virulence
at more distant sites (Leggett et al., 2012). The latter occurs
when pathogens cause secretion of proteins binding to host
cells (i.e., immune modulators delivered by the general secretary
pathway, or by Type I, II, and V secretory systems). This different
pathway or the synergetic effect of such pathways may lead to
differences in infective doses (Leggett et al., 2012). In addition
the host susceptibility is very relevant, now we know that the
genetic polymorphism in the host population determines the
variability observed in the type or intensity of responses against
the encountered specific pathogens ranging from asymptomatic
infections to fatal disease (Ribet and Cossart, 2015).
The concentrations of Aeromonas that were selected in the
exposure scenarios to assess risk of infection, were those that can
normally be found in oysters, i.e., MPN 9.3/100 g or 10 cfu/100 ml
have been reported in several drinking water studies (Abeyta
et al., 1986; Austin et al., 1996; Figueras et al., 2005; Egorov et al.,
2011; Robertson et al., 2014) or for instance in Milk (1−2× 103)
or meat products (102−103) as found by Borrell et al. (1998).
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FIGURE 6 | Risk of infection (upper graphic) and illness (lower graphic)
for the three different dose scenarios Aeromonas exposure (10, 1000,
and 106 cfu).
In fact a MPN 9.3/100g was the concentration of Aeromonas
found in oysters considered to be the source of an outbreak that
affected 472 persons suffering from gastroenteritis in Louisiana
(Abeyta et al., 1986). Concentrations as high as 105 or 106
cfu/100 ml can be found in treated wastewater and in reclaimed
waters used for irrigation of vegetables (Austin et al., 1996;
McMahon and Wilson, 2001; Janda and Abbott, 2010; Fernandez-
Cassi et al., 2016). Such sources could contaminate ready to eat
vegetables and pose a risk for human health as was recently
demonstrated finding the same genotype of Aeromonas in the
irrigated water and in the irrigated vegetables as commented
above (Latif-Eugenín, 2015).
The dose response assessment reported here shows that when
Aeromonas is present, the probability of infection may not be
negligible, and in a susceptible host, there may be a high risk of
acute enteric illness. It is therefore important to determine how
rare it is for a host to be highly susceptible. Outbreaks or other
natural experiments are hard to find. This may be because they
are so rare, but there could be underreporting because Aeromonas
is often not considered among the microbes to be analyzed
during investigation of outbreaks of infectious gastroenteritis
(Janda and Abbott, 2010; Figueras and Beaz-Hidalgo, 2015). In
fact the recognition of Aeromonas in the clinical setting occurs
accidentally on routine enteric isolation media designed for other
enteropathogens like XLD (MacConkey, Xylose Lysine Dextrose
Agar), SS (Salmonella–Shigella Agar), or CIN (Cefsulodin–
Irgasa–Novobiocin Agar) as described earlier (Figueras, 2005;
Janda and Abbott, 1998, 2010; Figueras and Beaz-Hidalgo, 2015).
The carriage of an infectious microorganism in the general
population cannot be easily extrapolated from (observable)
symptomatic cases, because of underreporting, but also because
in the population at large, a great majority of the infections may
remain asymptomatic. Biomarker studies using serum antibodies
for estimating infection (seroconversion) rates in the general
population have shown that for Campylobacter there may be
more than 1,000 asymptomatic infections for every notified
case of campylobacteriosis (Teunis et al., 2012b, 2013). Similar
ratios have been found for Salmonella (Simonsen et al., 2011).
Serology could be helpful in determining whether there could
be substantial carriage of Aeromonas in the general population.
Serological evidence of infection has been provided in some
cases, supporting the true enteropathogenicity of Aeromonas
(see review by Janda and Abbott, 1998; Crivelli et al., 2001).
In fact a specific secretory immunoglobulin A (sIgA) response
at the intestinal mucosa against the extracellular products that
appeared in the feces of patients with Aeromonas diarrhea was
demonstrated by Crivelli et al. (2001).
Prevalence or incidence of HIV, hepatitis C have been
estimate using the “evidence synthesis”, that is a well-accepted
methodology for integrating various sources of data to estimate
a quantity of interest for which there are no or limited direct data
(McDonald et al., 2015 and references therein). This approach
was applied recently to determine the incidence of symptomatic
pertussis infection in the Netherlands (McDonald et al., 2015)
and may help in determining whether the low numbers of
symptomatic cases are consistent with frequent isolation of
Aeromonas.
The predicted risks of infection and illness show considerable
uncertainty. This is caused by the variation observed between
outcomes produced by different strains, but it also results from
the small sizes of the exposed groups, in particular in the
challenge study (Table 1). Unfortunately it is not likely that there
will be more or better data available, to improve the precision of
the estimates. Despite the small sample sizes and uncertain doses,
what is relevant is that the low and high susceptibility estimates
are clearly different.
Aeromonas is a True Enteropathogen
Arguments used against considering Aeromonas an
enteropathogen, i.e., the lack of outbreaks, the non-fulfillment
of the Koch’s postulates, the low numbers of acute illness in the
human challenge study and the lack of animal model have all
been addressed with evidence to the contrary in other studies
(Chu et al., 2006; Figueras et al., 2007b; von Graevenitz, 2007;
Janda and Abbott, 2010; Figueras and Beaz-Hidalgo, 2015).
A murine model of Aeromonas diarrhea has been developed
(Abuelsaad et al., 2013). The Koch’s postulates have been
fulfilled by considering the incidental ingestion of A. trota by a
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laboratory worker (Carnahan et al., 1991), the challenge study
of Morgan et al. (1985) and the outbreak reports included in
this study (Krovacek et al., 1995; Granum et al., 1998; Zhang
et al., 2012). In addition, even though few outbreaks exist,
an epidemiological link has been found between the source of
infection and the clinical isolates. The same Aeromonas strains
(verified by genotyping) that caused diarrhea were isolated from
drinking water (Khajanchi et al., 2010; Pablos et al., 2011), from
the consumed shrimp cocktail (Altwegg et al., 1991) and from
the household environment (Demarta et al., 2000). Also the same
genotype of Aeromonas has been isolated from an HIV/AIDS
patient suffering from gastroenteritis and from their household
drinking-water (Ramalivhana et al., 2010).
CONCLUDING REMARKS AND
PERSPECTIVES
Combined evidence collated from clinical studies in humans
and outbreaks shows that Aeromonas should be treated
as a human enteropathogen. Exposure to low doses of
Aeromonas sp. may lead to infection, but most infections may
remain asymptomatic. Given the omnipresence of Aeromonas
in the environment, seroprevalence studies in the general
population are needed to reveal frequent carriage. Further
investigations are needed to determine the specific combination
of host, environment and pathogen factors that lead to the
occurrence of acute enteric symptoms (illness) associated with
Aeromonas infections. The risk of illness may be considerable,
even when exposed to moderate doses as shown for the
studied outbreaks. Therefore, as suggested earlier, patients
with underlying malignancies or immunosuppressing conditions
should be closely supervised, considering the inherently high risk
of invasion and dissemination associated with this population
group.
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